MAGNETOM World
MAGNETOM World
  1. MAGNETOM World
  2. Virtual 11th MAGNETOM World Summit
  3. 11th MAGNETOM World Summit
  4. Abdominal and Oncological Imaging

Abdominal and Oncological Imaging

Free-breathing Abdominal MRI and Liver Fat Quantification1,3 

Holden Wu (David Geffen School of Medicine, University of California, Los Angeles, CA, USA) 

The Role of MRI in the Management of Diffuse Liver Disease

Kartik S. Jhaveri (University Health Network, Toronto, Canada)

Quantitative MR Imaging: Application in Pancreatic Diseases

Liang Zhu (Peking Union Medical College Hospital, Beijing, China)

Rectal Cancer Staging and Evaluation of Response

Bachir Taouli (Icahn School of Medicine at Mount Sinai, New York, NY, USA )

Minimal Invasive Image-guided Therapy of Primary and Secondary Liver Disease

Jurgen Fütterer (Radboud University Medical Center, Nijmegen, The Netherlands)

Malignant Bone Disease Imaging in the Era of Precision Medicine

Anwar Padhani (Mount Vernon Cancer Centre, London, UK)

Radiomics and AI in Cancer - Approaches and Analysis1

Masoom Haider (Sinai Health System & University Health Network, Toronto, Canada)

Graphic Recordings of lectures and sessions

Graphic Recording Abdominal

Abdominal and Oncological Imaging

The herein illustrated statements made by Siemens Healthineers’ customers are based on their own and discrete opinion. The speaker is responsible for obtaining permission to use any previously published figures or tables. The speaker is also responsible for obtaining permission to reproduce any photograph showing recognizable persons.
1
Some products/features (here mentioned) are not necessarily commercially available in all countries. Due to regulatory reasons their availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
2

The MRI restrictions (if any) of the metal implant must be considered prior to patient undergoing MRI exam. MR imaging of patients with metallic implants brings specific risks. However, certain implants are approved by the governing regulatory bodies to be MR conditionally safe. For such implants, the previously mentioned warning may not be applicable. Please contact the implant manufacturer for the specific conditional information. The conditions for MR safety are the responsibility of the implant manufacturer, not of Siemens Healthineers.

3

MR scanning has not been established as safe for imaging fetuses and infants less than two years of age. The responsible physician must evaluate the benefits of the MR examination compared to those of other imaging procedures.

4

Work in progress: the application is currently under development and is not for sale in the U.S. and in other countries. Its future availability cannot be ensured. Note: This feature may not be available in all regions/countries at the time of publication.

5

The product is not for sale in the U.S. Its future availability cannot be guaranteed.